Napredna pretraga

Pregled bibliografske jedinice broj: 948325

Serum chitotriosidase : a circulating biomarker in polycythemia vera


Krečak, Ivan; Gverić-Krečak, Velka; Rončević, Pavle; Bašić-Kinda, Sandra; Gulin, Josipa; Lapić, Ivana; Fumić, Ksenija; Ilić, Ivana; Horvat, Ivana; Zadro, Renata et al.
Serum chitotriosidase : a circulating biomarker in polycythemia vera // Hematology (Luxembourg), 23 (2018), 10; 793-802 doi:10.1080/10245332.2018.1498157 (međunarodna recenzija, članak, znanstveni)


Naslov
Serum chitotriosidase : a circulating biomarker in polycythemia vera

Autori
Krečak, Ivan ; Gverić-Krečak, Velka ; Rončević, Pavle ; Bašić-Kinda, Sandra ; Gulin, Josipa ; Lapić, Ivana ; Fumić, Ksenija ; Ilić, Ivana ; Horvat, Ivana ; Zadro, Renata ; Holik, Hrvoje ; Coha, Božena ; Peran, Nena ; Aurer, Igor ; Duraković, Nadira

Izvornik
Hematology (Luxembourg) (1024-5332) 23 (2018), 10; 793-802

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Chitinase ; biomarker ; chitotriosidase ; cytokines ; essential thrombocythemia ; myelofibrosis ; myeloproliferative neoplasm ; polycythemia vera

Sažetak
Serum chitotriosidase activity (CHIT1) is a biomarker of macrophage activation with an important role in inflammation-induced tissue remodeling and fibrosis. Macrophages have been described to play a crucial role in regulating pathological erythropoiesis in polycythemia vera (PV). The aim of this study was to evaluate CHIT1 in patients diagnosed with Philadelphia-negative myeloproliferative neoplasms (MPNs). Using fluorometric assay, we measured CHIT1 in 28 PV, 27 essential thrombocythemia (ET), 17 primary myelofibrosis (PMF), 19 patients with secondary myelofibrosis and in 25 healthy controls. CHIT1 was significantly higher in PV (p < .001) and post- PV myelofibrosis (MF) transformation (post-PV MF) (p = .020), but not in ET (p = .080), post- ET MF transformation (p = .086), and PMF patients (p = .287), when compared to healthy controls. CHIT1 in PV was positively correlated with hemoglobin (p = .026), hematocrit (p = .012), absolute basophil count (p = .030) and the presence of reticulin fibrosis in the bone marrow (p = .023). A positive correlation between CHIT1 and these distinct laboratory PV features might imply macrophages closely related to clonal erythropoiesis as cells of CHIT1 origin. In addition, a positive association between CHIT1 and reticulin fibrosis might indicate its potential role in PV progression. CHIT1 might be considered as a circulating biomarker in PV. Additional studies are needed to clarify the role of CHIT1 in promoting disease progression and bone marrow fibrosis in PV.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove
Farmaceutsko-biokemijski fakultet, Zagreb,
Medicinski fakultet, Zagreb,
Opća bolnica Šibenik,
Opća bolnica "Dr. Josip Benčević",
Klinički bolnički centar Zagreb

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Uključenost u ostale bibliografske baze podataka:


  • EMBASE (Excerpta Medica)
  • CML LEUKAEMIA AND LYMPHOMA


Citati